Continuing its impressive history of philanthropy, the Dove Family Foundation of Dothan has provided a generous gift to the UAB Comprehensive Diabetes Center (UCDC), where researchers and clinicians are involved in cutting-edge research into the causes and mechanisms of diabetes. The Dove Family Foundation is supporting UAB’s innovative efforts to find a cure for type 1 diabetes.
“We are working very hard to develop novel and better therapies for diabetes and have identified a promising target in this regard,” says Anath Shalev, M.D., director of the UCDC. “Based on these findings, we are now in the process of developing a new class of drugs that promotes the patient’s own beta cell survival and insulin production.”
Shalev says this new class of drugs not only could improve blood sugar control, but also reduce or eliminate the need for insulin injections, preventing related complications. This research is a major undertaking that includes the screening and analysis of 300,000 compounds.
“None of this would have been possible without the Dove Family Foundation’s most recent gift as well as their past generous support of our efforts,” Shalev says. “The Dove family is having a huge impact on the quest for a new, curative diabetes treatment.”
“We have great confidence in the future of diabetes therapies due to the leadership of Dr. Shalev and her outstanding staff at the UAB Comprehensive Diabetes Center,” says Reid Dove, who is also a founding member of the UAB Comprehensive Diabetes Center Community Advisory Board. Robin and Reid Dove have been devoted to funding research toward a cure since their son Hal was diagnosed with type 1 diabetes in August 2006.
“We are delighted to play a role in this effort on behalf of all children and adults affected by type 1 diabetes,” Dove continues. “It is our hope that this gift can help accelerate the real-world use and application of their research.”
For more information about giving to the Comprehensive Diabetes Center, visit www.uab.edu/medicine/diabetes.